Related Experiment Videos
Orbital exenteration: a 13 year Manchester experience.
I Rahman1, A E Cook, B Leatherbarrow
1Manchester Royal Eye Hospital, Lister Centre, Nelson Street, Manchester M13 9WL, UK. imran1973@tiscali.co.uk
The British Journal of Ophthalmology
|September 20, 2005
Summary
Orbital exenteration, a major surgery for eye cancers, is increasingly common, often due to basal cell carcinomas. Early aggressive treatment may reduce the need for this disfiguring procedure.
Area of Science:
- Ophthalmology
- Oncology
- Plastic Surgery
Background:
- Orbital exenteration is a disfiguring surgical procedure for life-threatening orbital conditions.
- The study reviews the Manchester Royal Eye Hospital's experience with orbital exenteration.
- An increase in exenterations over 15 months prompted this review.
Purpose of the Study:
- To review indications for orbital exenteration.
- To analyze outcomes of orbital exenteration.
- To investigate reasons for an increasing rate of exenterations.
Main Methods:
- Retrospective study of orbital exenteration cases from 1991-2004.
- Data collected from operating department records and supplemented by general practitioner and hospital records.
- Identified 68 patients (69 orbits) who underwent the procedure.
Main Results:
- The most common indications were basal cell carcinoma (28), melanoma (10), and sebaceous cell carcinoma (9).
- An increasing incidence of basal cell carcinomas requiring exenteration was noted.
- Most patients (30) received orbital prosthesis within 11 months post-surgery.
Conclusions:
- Orbital exenteration rates are increasing, primarily due to basal cell carcinomas.
- Many patients had prior treatments elsewhere, suggesting potential for earlier intervention.
- Aggressive primary tumor removal may reduce the incidence of exenteration; rehabilitation is lengthy.